. 2022 Jan 21;31(2):202–211. doi: 10.1177/09612033211073670
© The Author(s) 2022
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 2.
Patient selection. OD, organ damage; SLE, systemic lupus erythematosus.